-
Drugs
-
Drug and Biologic Approval Reports
NDA Approvals by Therapeutic Potential and Chemical Type
Accelerated and Restricted Approvals Under Subpart H (drugs) and Subpart E (biologics)
IND Reports
-
NME Drug and New Biologic Approvals
CDER New Molecular Entity (NME) Drug and New Biologic Approvals
-
-
Priority New Drug Application (NDA) and Biologic License Application (BLA) Approvals
Priority New Drug Application (NDA) and Biologic License Application (BLA) Approvals
-
-
Efficacy Supplement Approvals
Efficacy Supplement Approvals
-
-
Approval Reports
-
-
Fast Track Reports
-
-
-